Ent-11α-hydroxy-15-oxo-kaur-16-en-19-oic-acid induces apoptosis and cell cycle arrest in CNE-2Z nasopharyngeal carcinoma cells

Oncology Reports

Volumn 29, Issue 6, 2013, Pages 2101-2108

  Wu, Kefeng ^a   Liu, Yi ^a,b   Lv, Yingnian ^a   Cui, Liao ^a   Li, Wende ^a   Chen, Jianfa ^c   Liang, Nian Ci ^a   Li, Li ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c Department of General Surgery   (China)

Author keywords

Cisplatin; Ent 11 hydroxy 15 oxo kaur 16 en 19 oic acid; Naso pharyngeal carcinoma; NF B; p53

Indexed keywords

CISPLATIN; CYTOCHROME C; ENT 11ALPHA HYDROXY 15 OXO KAUR 16 EN 19 OIC ACID; I KAPPA B KINASE; PLANT MEDICINAL PRODUCT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BRAKE FERN; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE ARREST; CELL VIABILITY; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFICACY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PTERIS SEMIPINNATA; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CISPLATIN; DITERPENES; DNA MUTATIONAL ANALYSIS; DRUG SYNERGISM; G2 PHASE CELL CYCLE CHECKPOINTS; HUMANS; I-KAPPA B PROTEINS; MOLECULAR SEQUENCE DATA; NASOPHARYNGEAL NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; SEQUENCE DELETION; TRANSCRIPTION FACTOR RELA; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84876213547     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2375     Document Type: Article

References (47)

1. Chen WQ, Zeng HM, Zheng RS, Zhang SW and He J: Cancer incidence and mortality in China, 2007. Chin J Cancer Res 24: 1-8, 2012.
2. Chang JT, Ko JY and Hong RL: Recent advances in the treatment of nasopharyngeal carcinoma. J Formos Med Assoc 103: 496-510, 2004. (Pubitemid 39386607)
3. Li L, Chen GG, Lu YN, Liu Y, Wu KF, Gong XL, Gou ZP, Li MY and Liang NC: Ent-11α-hydroxy-15-oxo-kaur-16-en-19-oic-acid inhibits the growth of human lung cancer A549 cells by arresting cell cycle and triggering apoptosis. Chin J Cancer Res 24: 109-115, 2012.
4. Vlantis AC, Lo CS, Chen GG, Ci Liang N, Lui VW, Wu K, Deng YF, Gong X, Lu Y, Tong MC and van Hasselt CA: Induction of laryngeal cancer cell death by Ent-11-hydroxy-15-oxo-kaur-16-en-19-oic acid. Head Neck 32: 1506-1518, 2010.
5. Liu ZM, Chen GG, Vlantis AC, Liang NC, Deng YF and van Hasselt CA: Cell death induced by ent-11alpha-hydroxy-15-oxo-kaur-16-en-19-oic-acid in anaplastic thyroid carcinoma cells is via a mitochondrial-mediated pathway. Apoptosis 10: 1345-1356, 2005. (Pubitemid 43117680)
6. Liu Z, Ng EK, Liang NC, Deng YF, Leung BC and Chen GG: Cell death induced by Pteris semipinnata L. is associated with p53 and oxidant stress in gastric cancer cells. FEBS Lett 579: 1477-1487, 2005. (Pubitemid 40289199)
7. Chen GG, Liang NC, Lee JF, Chan UP, Wang SH, Leung BC and Leung KL: Over-expression of Bcl-2 against Pteris semipinnata L-induced apoptosis of human colon cancer cells via a NF-kappa B-related pathway. Apoptosis 9: 619-627, 2004. (Pubitemid 39158638)
8. Gu SY, Zhao WP, Zeng Y, Tang WP, Zhao ML, Deng HH and Li K: New human nasopharyngeal epithelial cell line estab lished from a patient with poorly differentiated nasopharyngeal carcinoma. Chin J Cancer 2: 70-72, 1983.
9. Deng YF and Liang NC: Study on extraction and separation of diterpenoids from Pteris semipinnata. Chin Pharm J 39: 742-744, 2004.
10. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996.
11. Nigg EA: Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays 17: 471-480, 1995.
12. Gautier J, Solomon MJ, Booher RN, Bazan JF and Kirschner MW: cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell 67: 197-211, 1991.
13. Jiang M, Wei Q, Pabla N, Dong G, Wang CY, Yang T, Smith SB and Dong Z: Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity. Biochem Pharmacol 73: 1499-1510, 2007.
14. 1 cells and rats. Biol Pharm Bull 29: 2436-2441, 2006.
15. Satoh M, Kashihara N, Fujimoto S, Horike H, Tokura T, Namikoshi T, Sasaki T and Makino H: A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo. J Pharmacol Exp Ther 305: 1183-1190, 2003. (Pubitemid 36617997)
16. Van Waes C: Nuclear factor-kappaB in development, prevention, and therapy of cancer. Clin Cancer Res 13: 1076-1082, 2007.
17. Senderowicz AM: Targeting cell cycle and apoptosis for the treatment of human malignancies. Curr Opin Cell Biol 16: 670-678, 2004.
18. Skladanowski A, Côme MG, Sabisz M, Escargueil AE and Larsen AK: Down-regulation of DNA topoisomerase IIalpha leads to prolonged cell cycle transit in G2 and early M phases and increased survival to microtubule- interacting agents. Mol Pharmacol 68: 625-634, 2005. (Pubitemid 41206016)
19. Cho JH, Lee JG, Yang YI, Kim JH, Ahn JH, Baek NI, Lee KT and Choi JH: Eupatilin, a dietary flavonoid, induces G2/M cell cycle arrest in human endometrial cancer cells. Food Chem Toxicol 49: 1737-1744, 2011.
20. WAF1/CIP1 induction and JNK inactivation. BMC Cancer 11: 9, 2011.
21. Kalimutho M, Minutolo A, Grelli S, Formosa A, Sancesario G, Valentini A, Federici G and Bernardini S: Satraplatin (JM-216) mediates G2/M cell cycle arrest and potentiates apoptosis via multiple death pathways in colorectal cancer cells thus overcoming platinum chemo-resistance. Cancer Chemother Pharmacol 67: 1299-1312, 2011.
22. Huang WW, Ko SW, Tsai HY, Chung JG, Chiang JH, Chen KT, Chen YC, Chen HY, Chen YF and Yang JS: Cantharidin induces G2/M phase arrest and apoptosis in human colorectal cancer colo 205 cells through inhibition of CDK1 activity and caspase-dependent signaling pathways. Int J Oncol 38: 1067-1073, 2011.
23. Dia VP and Mejia EG: Lunasin promotes apoptosis in human colon cancer cells by mitochondrial pathway activation and induction of nuclear clusterin expression. Cancer Lett 295: 44-53, 2010.
24. Abbas T and Dutta A: p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9: 400-414, 2009.
25. Vousden KH and Prives C: Blinded by the light: the growing complexity of p53. Cell 137: 413-431, 2009.
26. Chu G: Cellular responses to cisplatin: The roles of DNA-binding proteins and DNA repair. J Biol Chem 269: 787-790, 1994.
27. Malugin A, Kopecková P and Kopecek J: HPMA copolymer-bound doxorubicin induces apoptosis in ovarian carcinoma cells by the disruption of mitochondrial function. Mol Pharm 3: 351-361, 2006. (Pubitemid 44021441)
28. Yim EK, Lee KH, Bae JS, Namkoong SE, Um SJ and Park JS: Proteomic analysis of antiproliferative effects by treatment of 5-fluorouracil in cervical cancer cells. DNA Cell Biol 23: 769-776, 2004.
29. Boulikas T and Vougiouka M: Cisplatin and platinum drugs at the molecular level (Review). Oncol Rep 10: 1663-1682, 2003.
30. Lin JP, Yang JS, Lee JH, Hsieh WT and Chung JG: Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line. World J Gastroenterol 12: 21-28, 2006.
31. Hwang JM, Kuo HC, Tseng TH, Liu JY and Chu CY: Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells. Arch Toxicol 80: 62-73, 2006.
32. Mantena SK, Sharma SD and Katiyar SK: Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther 5: 296-308, 2006.
33. Kuo CL, Chou CC and Yung BY: Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells. Cancer Lett 93: 193-200, 1995.
34. Vaux DL and Korsmeyer SJ: Cell death in development. Cell 96: 245-254, 1999. (Pubitemid 29059354)
35. Aggarwal BB: Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203-208, 2004.
36. Sun W, Guo MM, Han P, Lin JZ, Liang FY, Tan GM, Li HB, Zeng M and Huang XM: Id-1 and the p65 subunit of NF-κB promote migration of nasopharyngeal carcinoma cells and are correlated with poor prognosis. Carcinogenesis 33: 810-817, 2012.
37. Zhang Y, Lang JY, Liu L, Wang J, Feng G, Jiang Y, Deng YL, Wang XJ, Yang YH, Dai TZ, Xie G, Pu J and Du XB: Association of nuclear factor κB expression with a poor outcome in nasopha ryngeal carcinoma. Med Oncol 28: 1338-1342, 2011.
38. Gupta S, Hastak K, Afaq F, Ahmad N and Mukhtar H: Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis. Oncogene 23: 2507-2522, 2004. (Pubitemid 38520748)
39. Miyajima A, Nakashima J, Yoshioka K, Tachibana M, Tazaki H and Murai M: Role of reactive oxygen species in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder cancer cells. Br J Cancer 76: 206-210, 1997. (Pubitemid 27279660)
40. Meijer C, Mulder NH, Timmer-Bosscha H, Zijlstra JG and de Vries EG: Role of free radicals in an adriamycin-resistant human small cell lung cancer cell line. Cancer Res 47: 4613- 4617, 1987.
41. Sausville EA, Stein RW, Peisach J and Horwitz SB: Properties and products of the degradation of DNA by bleomycin and iron (II). Biochemistry 17: 2746-2754, 1978. (Pubitemid 8385273)
42. Yamauchi N, Kuriyama H, Watanabe N, Neda H, Maeda M and Niitsu Y: Intracellular hydroxyl radical production induced by recombinant human tumor necrosis factor and its implication in the killing of tumor cells in vitro. Cancer Res 49: 1671-1675, 1989. (Pubitemid 19108385)
43. Chirino YI and Pedraza-Chaverri J: Role of oxidative and nitro sative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol 61: 223-242, 2009.
44. Rybak LP, Whitworth CA, Mukherjea D and Ramkumar V: Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res 226: 157-167, 2007. (Pubitemid 46428033)
45. van den Berg JH, Beijnen JH, Balm AJ and Schellens JH: Future opportunities in preventing cisplatin induced ototoxicity. Cancer Treat Rev 32: 390-397, 2006. (Pubitemid 44063878)
46. Chen GG, Leung J, Liang NC, Li L, Wu K, Chan UP, Leung BC, Li M, Du J, Deng YF, Gong X, Lv Y, Chak EC and Lai PB: Ent-11α-hydroxy-15-oxo-kaur-16- en-19-oic-acid inhibits hepatocellular carcinoma in vitro and in vivo via stabilizing IκBα. Invest New Drugs 30: 2210-2218, 2012.
47. Li MY, Leung J, Kong AW, Liang NC, Wu K, Hsin MK, Deng YF, Gong X, Lv Y, Mok TS, Underwood MJ and Chen GG: Anticancer efficacy of 5F in NNK-induced lung cancer development of A/J mice and human lung cancer cells. J Mol Med 88: 1265-1276, 2010.